News
Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary ...
The global preeclampsia drug market is poised for significant growth due to increasing awareness, advancements in diagnostics, and a higher prevalence of hypertension in pregnant women. Preeclampsia, ...
Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second ...
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, July 17th: ProKidney Corp. PROK: This clinical-stage biotechnology company has a Zacks Rank #1 ...
The latest Pharming Group NV American Depositary Shares Repr 10 Shs Reg S stock prices, stock quotes, news, and PHAR history to help you invest and trade smarter.
The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...
A teenager who lost her mother, aunt and uncle to a genetic condition has become the first person in Europe to receive a ...
Access AS:PHAR financials, view the annual report and financial statements, including income statement, balance sheet, cash flow.
KalVista Pharma has finally received FDA approval for its oral kallikrein inhibitor sebetralstat, becoming the first treatment in the US that can provide oral, on-demand treatment of hereditary ...
Breakthrough for teen who lost four family members to inherited condition Mary Catchpole, 19, has the same life-threatening genetic condition, activated PI3-Kinase delta syndrome (APDS) ...
A Cambridge teen has become the first person in Europe to receive a “life-changing” drug for a rare genetic condition which contributed to the early deaths of her mother, aunt, uncle and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results